Celldex Therapeutics (CLDX) Research & Development (2010 - 2026)
Celldex Therapeutics' Research & Development was $67.54 million in Q2 2026, up 24.6% from $54.2 million a year earlier but down 7.5% from the prior quarter.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Research & Development (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Celldex Therapeutics' Research & Development was $278.81 million through Jun 30, 2026, up 40.1% year-over-year; for FY2025, it was $245.07 million, up 49.8% from FY2024.
- Research & Development has now increased for five consecutive years, with a five-year compound annual growth rate of 41.9% (FY2020 to FY2025).
- In earlier years, Research & Development was $163.55 million in FY2024 (+38.6%), $118.01 million in FY2023 (+43.5%), $82.26 million in FY2022 (+54.3%) and $53.31 million in FY2021 (+25.3%).
- Quarterly Research & Development has moved between $13.56 million (Q3 2021) and $75.33 million (Q4 2025) over five years.
- Compared with a year earlier, Research & Development has increased for 23 straight quarters, with growth averaging 43.9% over the last eight quarters.
- Over the past five years, the year-over-year growth in Research & Development ranged from 18.1% (Q1 2024) to 67.8% (Q2 2022).
- Per Business Quant data, CLDX's Research & Development in the three quarters before Q2 2026 was $73 million (Q1 2026), $75.33 million (Q4 2025) and $62.93 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Celldex Therapeutics | 2.47 Bn | 2.47 Bn | - | 67.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 67.54 Mn |
| Mar 31, 2026 | 73.00 Mn |
| Dec 31, 2025 | 75.33 Mn |
| Sep 30, 2025 | 62.93 Mn |
| Jun 30, 2025 | 54.20 Mn |
| Mar 31, 2025 | 52.61 Mn |
| Dec 31, 2024 | 46.94 Mn |
| Sep 30, 2024 | 45.26 Mn |
| Jun 30, 2024 | 39.69 Mn |
| Mar 31, 2024 | 31.66 Mn |
| Dec 31, 2023 | 30.43 Mn |
| Sep 30, 2023 | 34.54 Mn |
| Jun 30, 2023 | 26.25 Mn |
| Mar 31, 2023 | 26.80 Mn |
| Dec 31, 2022 | 22.90 Mn |
| Sep 30, 2022 | 21.57 Mn |
| Jun 30, 2022 | 20.73 Mn |
| Mar 31, 2022 | 17.06 Mn |
| Dec 31, 2021 | 14.68 Mn |
| Sep 30, 2021 | 13.56 Mn |
API Access
Celldex Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CLDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CLDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CLDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();